MENU
KYNB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Kyntra Bio (KYNB) Ownership - Who owns Kyntra Bio?

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
27.12M
P/E Ratio
N/A
Total Cash
87.24M
Projected Growth
N/A
Total Debt
N/A
Revenue
7.44M
Risk (Beta)
1.52
Dividend Yield
N/A
Total Cash/Share
21.55
Total Debt/Equity
N/A
Revenue/Share
1.84 USD as % of share price
View a ticker or compare two or three
KYNB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details